Critical & Chronic Care >
I.V. Site Dressings > 3M™ Tegaderm™ CHG Chlorhexidine Gluconate IV Securement Dressing 1659
3M™ Tegaderm™ CHG Chlorhexidine Gluconate IV Securement Dressing 1659
3M ID
70200764044
UPC#
50707387578331
CAT#
1659
4 inch x 6-1/8 inch (10cm x 15,5cm) CHG Chlorhexidine Gluconate IV Securement Dressing
Benefits
Proven to be as effective as, or better at, reducing skin flora on healthy volunteers for up to 10 days than BIOPATCH{1}.
Proven to be more effective at preventing re-growth on healthy volunteers at 7 days than BIOPATCH{1}.
Transparent, allowing continuous visualization of insertion site.
Integrated design of dressing and CHG gel pad reduces application steps and minimizes potential for application error.
As easy-to-use and easy-to-train as a Tegaderm™ dressing.
Large surface area to provide coverage of catheter and suture sites.
Absorbs fluid.
Larger coverage area than BIOPATCH{1} allows for coverage of sutures as well as insertion site.
{1} - Trademark ETHICON, INC.
Suggested Applications
Non-tunneled central venous catheters (CVC), inserted in the internal jugular, subclavian, or femoral vein
Peripherally Inserted Central Catheters (PICCs)
Tunneled CVCs
Arterial catheters
Dialysis catheters
Midline catheters
Any percutaneous device Integrates the powerful antimicrobial effectiveness of CHG with a simple, transparent IV film dressing.
Specifications
Brand
Tegaderm
Condition
I.V. Related
Department
Cardiovascular, Dialysis Center, Emergency, I.V. Therapy, Intensive Care Unit, Medical-Surgical, Oncology, Operating Room-Surgery, Pediatrics, Radiology, Urgent Care, Wound Care
Dressing Type
Film Dressing
IV Related Condition Type
Arterial Catheter, CVC Dialysis, CVC Implanted Port, CVC PICC, CVC Short-term, CVC Tunneled, Epidural Catheter, PIV
Product Type
Antimicrobial Dressing
Clinicals
Tegaderm CHG IV Evaluation of Gel Pad Drsg
(PDF, 1.1MB)
Tegaderm CHG IV Growth Inhibitions of Microorganisms
(PDF, 385.5KB)
Use of CHG on Central Line Insertion Sites, pdf
(PDF, 103.7KB)
Clinical Performance of Chlorhexidine Gluconate
(PDF, 179.9KB)
Study of Bloodstream Infection Rates
(PDF, 448.0KB)
Suppression of Regrowth under CHG Drsg
(PDF, 429.9KB)
Tegaderm CHG Drsg: Antimicrobial Activity for IV Site Evaluation
(PDF, 211.4KB)
Tegaderm CHG Gel Dressing Absorption - Poster - Lo Res - English
(PDF, 978.5KB)
Tegaderm CHG Drsg: Park Nicollet Methodist Hospital Evaluation
(PDF, 608.5KB)
Migration of Chlorhexidine Gluconate Clinical
(PDF, 162.6KB)
Novel Integrated Chlorhexidine-impregnated Dressing, Dr. Maki
(PDF, 1.3MB)
Clinical Performance of Chlorhexidine Gel Pad, Mark Rupp
(PDF, 787.9KB)
Tegaderm CHG Drsg: Multicenter Prospective Open Label Evaluation
(PDF, 2.3MB)
